123 related articles for article (PubMed ID: 38376276)
21. High gene expression levels of VEGFA and CXCL8 in the peritumoral brain zone are associated with the recurrence of glioblastoma: A bioinformatics analysis.
Luo X; Xu S; Zhong Y; Tu T; Xu Y; Li X; Wang B; Yang F
Oncol Lett; 2019 Dec; 18(6):6171-6179. PubMed ID: 31788092
[TBL] [Abstract][Full Text] [Related]
22. Identification of Key Gene Targets for Sensitizing Colorectal Cancer to Chemoradiation: an Integrative Network Analysis on Multiple Transcriptomics Data.
Manoochehri H; Jalali A; Tanzadehpanah H; Taherkhani A; Saidijam M
J Gastrointest Cancer; 2022 Sep; 53(3):649-668. PubMed ID: 34432208
[TBL] [Abstract][Full Text] [Related]
23. Identification of potential biomarkers with colorectal cancer based on bioinformatics analysis and machine learning.
Hammad A; Elshaer M; Tang X
Math Biosci Eng; 2021 Oct; 18(6):8997-9015. PubMed ID: 34814332
[TBL] [Abstract][Full Text] [Related]
24. Identification of Hub Genes and Key Pathways Associated with Peripheral T-cell Lymphoma.
Gao HX; Wang MB; Li SJ; Niu J; Xue J; Li J; Li XX
Curr Med Sci; 2020 Oct; 40(5):885-899. PubMed ID: 32980897
[TBL] [Abstract][Full Text] [Related]
25. Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer.
Ebadfardzadeh J; Kazemi M; Aghazadeh A; Rezaei M; Shirvaliloo M; Sheervalilou R
Med Oncol; 2021 Aug; 38(9):114. PubMed ID: 34390411
[TBL] [Abstract][Full Text] [Related]
26. Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis.
Chen J; Wang Z; Shen X; Cui X; Guo Y
Mol Genet Genomic Med; 2019 Jul; 7(7):e00713. PubMed ID: 31087508
[TBL] [Abstract][Full Text] [Related]
27. Decoding Psoriasis: Integrated Bioinformatics Approach to Understand Hub Genes and Involved Pathways.
Choudhary S; Pradhan D; Khan NS; Singh H; Thomas G; Jain AK
Curr Pharm Des; 2020; 26(29):3619-3630. PubMed ID: 32160841
[TBL] [Abstract][Full Text] [Related]
28. Identification and prognostic analysis of candidate biomarkers for lung metastasis in colorectal cancer.
Liu Y; Liu C; Huang D; Ge C; Chen L; Fu J; Du J
Medicine (Baltimore); 2024 Mar; 103(11):e37484. PubMed ID: 38489730
[TBL] [Abstract][Full Text] [Related]
29. Identification of Core Genes and Pathways in Melanoma Metastasis via Bioinformatics Analysis.
Xie R; Li B; Jia L; Li Y
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054979
[TBL] [Abstract][Full Text] [Related]
30. Identification of hub genes and outcome in colon cancer based on bioinformatics analysis.
Yang W; Ma J; Zhou W; Li Z; Zhou X; Cao B; Zhang Y; Liu J; Yang Z; Zhang H; Zhao Q; Hong L; Fan D
Cancer Manag Res; 2019; 11():323-338. PubMed ID: 30643458
[TBL] [Abstract][Full Text] [Related]
31. Identification of prognostic risk factors for pancreatic cancer using bioinformatics analysis.
Jin D; Jiao Y; Ji J; Jiang W; Ni W; Wu Y; Ni R; Lu C; Qu L; Ni H; Liu J; Xu W; Xiao M
PeerJ; 2020; 8():e9301. PubMed ID: 32587798
[TBL] [Abstract][Full Text] [Related]
32. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
33. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
[TBL] [Abstract][Full Text] [Related]
34. Identification of Key Biomarkers and Potential Molecular Mechanisms in Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
Yang B; Dong K; Guo P; Guo P; Jie G; Zhang G; Li T
J Comput Biol; 2020 Jan; 27(1):40-54. PubMed ID: 31424263
[TBL] [Abstract][Full Text] [Related]
35. Integration of gene expression data identifies key genes and pathways in colorectal cancer.
Hozhabri H; Lashkari A; Razavi SM; Mohammadian A
Med Oncol; 2021 Jan; 38(1):7. PubMed ID: 33411100
[TBL] [Abstract][Full Text] [Related]
36. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
37. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
38. Molecular mechanisms investigation for liver metastasis of colorectal cancer by combined bioinformatic gene expression profile analysis.
Wu QQ; Wang XY; Wu WX; Chen YX; Wang J; Zhang X; Qian Y; Du SS; Sun J; Zeng ZC
Cancer Treat Res Commun; 2023; 35():100694. PubMed ID: 36868002
[TBL] [Abstract][Full Text] [Related]
39. Renal tubular gen e biomarkers identification based on immune infiltrates in focal segmental glomerulosclerosis.
Bai J; Pu X; Zhang Y; Dai E
Ren Fail; 2022 Dec; 44(1):966-986. PubMed ID: 35713363
[TBL] [Abstract][Full Text] [Related]
40. Identification of shared gene signatures and molecular mechanisms between chronic kidney disease and ulcerative colitis.
Liang Z; Hu X; Lin R; Tang Z; Ye Z; Mao R; Chen W; Zhou Y
Front Immunol; 2023; 14():1078310. PubMed ID: 36860851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
